A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Alison T. Stopeck, Joseph M. Unger, Lisa M. Rimsza, William T. Bellamy, Maria Iannone, Daniel Persky, Michael Leblanc, Richard Fisher, Thomas Miller

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108'. Together they form a unique fingerprint.

Medicine & Life Sciences